Bemfola is a fertility medication used to stimulate egg production in women undergoing assisted reproductive technologies, such as in vitro fertilization (IVF). It contains the active ingredient follitropin alfa, which is a recombinant form of the naturally occurring follicle-stimulating hormone (FSH). FSH is crucial in the process of ovulation, as it stimulates the growth of ovarian follicles, leading to the production and maturation of eggs. Bemfola is administered through subcutaneous injections, and its dosage is tailored to the individual's response, under the guidance of a healthcare professional. This medication is part of a broader category of treatments aimed at addressing infertility issues, offering hope to many individuals and couples wishing to conceive.